Why the Mediterranean diet isn't enough in perimenopause, and why precision nutrition might be the key

The Mediterranean diet has a genuinely strong evidence base. Whole foods, healthy fats, plenty of vegetables, moderate protein, minimal processed food: these are sound principles. For most of a woman's life, eating in this general direction serves her well.

And then perimenopause arrives.

Many women in this transition are doing everything the Mediterranean diet asks of them. They're eating well, training consistently, and gaining weight anyway. Their energy is erratic. Body composition is shifting despite nothing obvious changing in their behaviour. The food that sustained them for decades is no longer doing what it used to do.

This is not a failure of willpower or consistency. It is a shift in the underlying biology, and a general dietary framework, however well-intentioned, cannot address it precisely enough.

Here's what's actually happening, and why precision matters.

What estrogen decline does to your metabolism

During the menopausal transition, declining estrogen fundamentally changes how your body handles fuel. The relationship between hormones and metabolic function runs deep: estrogen influences insulin sensitivity, fat distribution, energy expenditure, and lipid metabolism. When its levels fall in a non-linear, unpredictable pattern across perimenopause, the body's ability to manage carbohydrates, regulate appetite, and partition energy all shift accordingly.

Visceral fat accumulation is one of the clearest consequences. As estrogen declines, fat redistribution moves centrally (to the abdomen) rather than to the gluteofemoral region (hips and thighs). Visceral fat is metabolically active tissue, and its accumulation is strongly associated with reduced insulin sensitivity, dyslipidemia, and increased inflammatory burden (Saarnio et al., EBioMedicine, 2021). This happens even when body weight stays relatively stable. The composition and location of fat changes before the scale moves at all.

From a glucose metabolism standpoint, the picture is important. The ZOE PREDICT study, one of the most detailed nutritional metabolic studies of menopause to date, confirmed that postmenopausal women show significantly altered postprandial metabolic responses compared to premenopausal women: higher blood glucose responses after meals, elevated triglyceride responses, and changes in gut microbiome composition that influence how carbohydrates are processed (Berry et al., Cell Metabolism, 2022).

What this means practically is that foods your body processed efficiently at 35 may produce meaningfully different glucose responses at 46. The carbohydrate tolerance has shifted. General dietary guidance built around population averages cannot account for that shift in you.

What the Mediterranean diet does well, and where it stops

A 2024 systematic review published in AIMS Public Health examined Mediterranean diet interventions specifically in menopausal women. It found benefits in weight, blood pressure, triglycerides, total cholesterol, and LDL levels across the included studies (Gonçalves et al., AIMS Public Health, 2024). These are meaningful outcomes. The Mediterranean pattern is anti-inflammatory, fibre-rich, and supports cardiovascular health in ways that matter for this life stage.

The limitation is not in the foods themselves. The limitation is in the resolution.

A Mediterranean diet tells you what category of foods to favour. It does not tell you how much carbohydrate your specific glucose metabolism can handle before it begins driving fat storage. It does not account for the fact that two women eating the same legume-rich meal can produce dramatically different blood glucose responses. Research from Weizmann Institute demonstrated this clearly: in an 800-person cohort, glycaemic responses to identical meals varied enormously between individuals, to the point that researchers concluded universal dietary recommendations have limited utility for many people (Zeevi et al., Cell, 2015). This finding has been replicated and extended in subsequent precision nutrition research.

For women in perimenopause, where insulin sensitivity is already shifting, this variability is not an abstract concern. It is the difference between eating in a way that supports your metabolic health and eating in a way that inadvertently worsens it, with foods you've been told are healthy.

What a blood marker-based approach adds

The Metabolic Balance programme, which I use in clinical practice through Sérenité, builds a personalised nutrition plan from 36 individual blood values alongside health history, food preferences, and individual measurements. This matters because blood markers give you information that food categories cannot.

Inflammatory markers such as C-reactive protein (CRP) show the degree of systemic inflammation an individual is carrying. Chronic low-grade inflammation is one of the mechanisms through which fat loss stalls and post-training recovery slows (Furman et al., Nature Medicine, 2019). Knowing where a woman sits on that spectrum allows for food choices that specifically reduce that burden, rather than following general anti-inflammatory eating principles that may or may not address her actual inflammatory picture.

Liver enzymes matter because the liver is central to hormone metabolism. Oestrogen is processed and cleared through hepatic detoxification pathways, and a liver carrying a higher metabolic burden will do this less efficiently. The result is that hormonal imbalances are compounded rather than addressed, regardless of whether a woman is using HRT or relying on endogenous hormone production.

Fasting glucose and insulin values indicate where a woman sits on the insulin sensitivity spectrum, which directly informs how many carbohydrates her body can process effectively before it begins storing the excess. The five-hour gap between meals built into the Metabolic Balance structure is not arbitrary. It allows insulin to return to baseline between eating occasions, which creates the conditions for the body to shift from glucose-burning to fat-burning as a primary fuel source: what researchers call metabolic flexibility. This is the capacity to switch between fuel substrates efficiently, and it is impaired in many perimenopausal women (Smith et al., Clinical Endocrinology, 2022).

The Metabolic Balance study published in the Journal of Nutrition and Metabolism followed participants for 12 months and found that nearly two thirds maintained clinically significant weight loss, with improvements in blood lipids and health-related quality of life. The authors attributed the programme's adherence rates to personalised food lists and individual coaching rather than generic instruction (Meisert and Wolf, Journal of Nutrition and Metabolism, 2010). More recent evidence from a randomised controlled trial comparing a personalised dietary programme against standard dietary advice found the personalised approach produced significantly greater reductions in triglycerides and improved cardiometabolic markers, particularly in women (Dahl et al., Nature Medicine, 2024).

Protein: the variable most general plans underestimate

For active women in perimenopause, protein adequacy is arguably the most consequential nutritional variable, and the one most consistently underestimated in general frameworks.

During the menopausal transition, two mechanisms drive net protein breakdown simultaneously. Enhanced protein catabolism increases the rate at which muscle protein is broken down. Anabolic resistance (a blunted ability to synthesise muscle protein from dietary protein) reduces the body's capacity to build it back (Simpson et al., BJOG, 2023). Together, they mean that the protein intake that maintained muscle mass at 38 will not do the same at 46.

Research in postmenopausal women has confirmed that older women require a higher per-meal protein dose than younger women to maximally stimulate muscle protein synthesis (McKenna et al., Journal of Applied Physiology, 2024). A narrative review from 2024 confirmed that most perimenopausal women are not reaching this threshold consistently (Mackay et al., Physiologia, 2024). Current evidence supports a target of 1.6 to 2.0g of protein per kilogram of body weight daily for active women in this life stage, distributed across meals rather than concentrated in one sitting, with a preference for high-quality, leucine-rich protein sources at each meal (Gatorade Sports Science Institute, citing Sims et al., 2023).

The Mediterranean diet does not specify this. It includes protein sources, but not the amounts, timing, or quality hierarchy that matter for muscle preservation in perimenopause. This is not a criticism of the framework. It simply was not designed for this level of resolution.

Personalisation is the only accurate approach

A 55-year-old woman who has been eating well by any standard measure but is gaining weight, losing muscle, sleeping poorly, and recovering slowly from training is not failing. She is experiencing a metabolic reality that general guidance was never specific enough to address.

Precision nutrition, built from her own blood values, health history, and individual responses, gives her something a population-based framework cannot: a plan calibrated to how her body is actually functioning right now, in this hormonal season.

Nutrition first, always. Protein adequacy, anti-inflammatory whole foods, stable blood sugar, and structured meal timing provide the metabolic foundation. Without that foundation, training produces limited adaptation, and HRT (where appropriate) produces limited benefit. Both interventions depend on the body's capacity to respond.

Training is medicine alongside it. Three sessions of heavy compound resistance training per week, with one to two high-intensity interval sessions, provides the mechanical stimulus that estrogen no longer delivers consistently. Muscle tissue requires that signal. Without it, the losses accelerate regardless of how well a woman is eating.

And where the blood work, symptoms, and clinical picture indicate it, hormone therapy provides the biological context in which all of the above works better.

The goal is never to eat less. It is to eat precisely, in a way that matches your biochemistry, supports your training, and gives your body what it is actually asking for. That is what good nutrition science makes possible.

That, my darlings, is the standard worth working toward.

References:

Berry, S.E., Valdes, A.M., Drew, D.A., Asnicar, F., Mazidi, M., Wolf, J., Capdevila, J., Hadjigeorgiou, G., Davies, R., Al Khatib, H., Bonnett, C., Ganesh, S., Bakker, E., Hart, D., Mangino, M., Sherrill-Mix, S., Chekmeneva, E., Trimmer, J., Patel, C.J., Merino, J., Linenberg, I., Cardoso, R., Nguyen, L.H., Rexrode, K.M., Chan, A.T., Franks, P.W., Spector, T.D. and Segata, N. (2022) 'Human postprandial responses to food and potential for precision nutrition', Cell Metabolism, 34(1), pp. 152–170.

Dahl, W.J., Morberg Hindborg, A., Hjorth, M.F., Ritz, C., Pedersen, J.A., Dragsted, L.O. and Larsen, T.M. (2024) 'Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial', Nature Medicine, 30, pp. 1888–1897.

Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D.W., Fasano, A., Miller, G.W., Miller, A.H., Mantovani, A., Weyand, C.M., Barzilai, N., Goronzy, J.J., Rando, T.A., Effros, R.B., Lucia, A., Kleinstreuer, N. and Slavich, G.M. (2019) 'Chronic inflammation in the etiology of disease across the life span', Nature Medicine, 25(12), pp. 1822–1832.

Gonçalves, C., Moreira, H. and Santos, R. (2024) 'Systematic review of Mediterranean diet interventions in menopausal women', AIMS Public Health, 11(1), pp. 110–129.

Mackay, H., Van Pelt, D.W. and Toth, M.J. (2024) 'The impact of protein in post-menopausal women on muscle mass and strength: a narrative review', Physiologia, 4(1), pp. 46–68.

McKenna, C.F., Askow, A.T., Paulussen, K.J.M., Salvador, A.F., Fang, H.Y., Ulanov, A.V., Li, Z., Paluska, S.A., Beals, J.W., Jäger, R., Purpura, M. and Burd, N.A. (2024) 'Postabsorptive and postprandial myofibrillar protein synthesis rates at rest and after resistance exercise in women with postmenopause', Journal of Applied Physiology, 136(3), pp. 544–555.

Meisert, A. and Wolf, O. (2010) 'Program adherence and effectiveness of a commercial nutrition program: the Metabolic Balance study', Journal of Nutrition and Metabolism, 2010, Article ID 197656.

Saarnio, E., Pekkinen, M., Itkonen, S.T., Kemi, V., Törmänen, S., Ivaska, K.K., Kärkkäinen, M., Laitinen, K., Väisänen, J.P., Pekkala, L., Sievänen, H. and Välimäki, M.J. (2021) 'Changes in adipose tissue phenotype related to metabolic dysfunction across menopause', EBioMedicine, 72, article 103606.

Simpson, S.J., Raubenheimer, D., Cogger, V.C., Macia, L., Solon-Biet, S.M., Le Couteur, D.G. and George, J. (2023) 'Weight gain during the menopause transition: evidence for a mechanism dependent on protein leverage', BJOG: An International Journal of Obstetrics and Gynaecology, 130(7), pp. 728–734.

Smith, G.I., Mittendorfer, B. and Klein, S. (2022) 'Metabolically healthy obesity: facts and fantasies', Journal of Clinical Investigation, 132(1), e148186.

Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., Suez, J., Mahdi, J.A., Matot, E., Malka, G., Kosower, N., Rein, M., Zilberman-Schapira, G., Dohnalová, L., Pevsner-Fischer, M., Bikovsky, R., Halpern, Z., Elinav, E. and Segal, E. (2015) 'Personalized nutrition by prediction of glycemic responses', Cell, 163(5), pp. 1079–1094.

If you're a woman in perimenopause struggling with metabolic health despite doing "all the right things," the missing piece might be understanding your unique internal landscape. My Sérenité Women's Wellness Program uses blood pathology analysis to create truly personalized nutrition protocols that work with your specific metabolism. Learn more about working together